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Abstract. 
 
Proteins contained on puriﬁed COPII vesi-
cles were analyzed by matrix-assisted laser desorption
ionization mass spectrometry combined with database
searching. We identiﬁed four known vesicle proteins
(Erv14p, Bet1p, Emp24p, and Erv25p) and an addi-
tional nine species (Yip3p, Rer1p, Erp1p, Erp2p,
Erv29p, Yif1p, Erv41p, Erv46p, and Emp47p) that had
not been localized to ER vesicles. Using antibodies, we
demonstrate that these proteins are selectively and efﬁ-
ciently packaged into COPII vesicles. Three of the
newly identiﬁed vesicle proteins (Erv29p, Erv41p, and
Erv46p) represent uncharacterized integral membrane
proteins that are conserved across species. Erv41p and
Erv46p were further characterized. These proteins co-
localized to ER and Golgi membranes and exist in a
detergent-soluble complex that was isolated by immu-
noprecipitation. Yeast strains lacking Erv41p and/or
Erv46p are viable but display cold sensitivity. The ex-
pression levels of Erv41p and Erv46p are interde-
pendent such that Erv46p was reduced in an 
 
erv41
 
D
 
strain, and Erv41p was not detected in an 
 
erv46
 
D
 
 strain.
When the 
 
erv41
 
D
 
 or 
 
ev46
 
D
 
 alleles were combined with
other mutations in the early secretory pathway, altered
growth phenotypes were observed in some of the dou-
ble mutant strains. A cell-free assay that reproduces
transport between the ER and Golgi indicates that de-
letion of the Erv41p–Erv46p complex inﬂuences the
membrane fusion stage of transport.
Key words: ER • Golgi • vesicles • coat proteins •
trafﬁcking
 
Introduction
 
Membrane-bound transport vesicles are central intermedi-
ates for intracellular trafficking of proteins and lipids. The
production of many types of transport vesicles depends on
coat protein complexes that form vesicles and select the
desired set of cargo (Schekman and Orci, 1996). Although
the importance of vesicle carriers has been appreciated,
the molecular mechanisms underlying distinct stages in
vesicle-mediated transport are not well understood. Sev-
eral approaches have been used to identify and character-
ize this protein machinery, including the isolation and
characterization of specific vesicle carriers involved in syn-
aptic transmission, endocytosis, exocytosis, and intra-
Golgi transport (for reviews see Söllner and Rothman,
1996; Arvan and Castle, 1998; Foletti et al., 1999; Smith
and Pearse, 1999). We have undertaken a comprehensive
analysis of ER-derived transport vesicles to elucidate the
molecular events associated with transport between the
ER and Golgi compartments.
Transport between these early compartments of the
secretory pathway is bidirectional and mediated by the
COPI and COPII coat complexes. In general, it is thought
that the COPII coat buds vesicles from the ER for antero-
grade transport, whereas the COPI coat is responsible for
retrograde transport of recycled proteins from Golgi and
pre-Golgi compartments back to the ER (Mellman and
Warren, 2000). Formation of COPII-coated vesicles may
be reproduced in a cell-free reaction with purified soluble
components (the Sar1p GTPase, the Sec23p complex, and
the Sec13p complex) and washed ER membranes (Salama
et al., 1993; Barlowe et al., 1994). A highly purified prepa-
ration of uncoated ER-derived vesicles can be obtained
through a scaled up version of the cell-free budding assay.
Examination of purified vesicles on protein-stained gels
reveals a characteristic set of polypeptides that are solubi-
lized by detergents but not by an elevated pH treatment
(Barlowe et al., 1994; Rexach et al., 1994). Some of the
 
abundant ER vesicle (Erv)
 
1
 
 proteins have been character-
ized (Barlowe et al., 1994; Schimmöller et al., 1995; Belden
and Barlowe, 1996; Powers and Barlowe, 1998) and are
found to cycle between the ER and Golgi compartments
and function in the processes of vesicle formation and/or
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Abbreviations used in this paper:
 
 CPY, carboxypeptidase Y; Erv, ER ves-
icle; gp-
 
a
 
-F, glyco-pro–
 
a
 
 factor; HA, hemagglutinin. 
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site-specific membrane fusion. In this report, we extend
our studies to identify additional Erv proteins contained
on ER-derived vesicles by mass spectrometry coupled to
database searching. Several new Erv proteins were identi-
fied and two of these, Erv41p and Erv46p, were character-
ized further. Erv41p and Erv46p exist in a complex that is
probably conserved across species and appears to influ-
ence the vesicle fusion stage of transport between the ER
and Golgi compartments.
 
Materials and Methods
 
Yeast Strains and Media
 
Strains used for this study are listed in Table I. Unless noted otherwise,
cultures were grown at 30
 
8
 
C in rich medium (YPD, 1% Bacto-yeast ex-
tract, 2% Bacto-peptone, 2% dextrose) or in minimal medium (YMD,
0.67% yeast nitrogen base without amino acids, 2% dextrose) containing
the appropriate amino acid supplements. Standard yeast (Sherman, 1991)
and cloning protocols (Ausubel et al., 1987) were used.
 
Plasmid Construction
 
Primer sequences are listed in Table II. The sequences of 
 
ERV41
 
(YML067c)
 
 
 
and
 
 ERV46
 
 (YAL042w) were obtained from the 
 
Saccharo-
myces
 
 Genome Database. To generate plasmid pRS424-
 
ERV41
 
, the
 
ERV41
 
 sequence, and 
 
z
 
300 bp of its flanking upstream and downstream,
sequences were cloned from genomic DNA prepared from strain RSY255
using primers YML067c-NotI and YML067c-BamHI. The product was li-
gated into the NotI and BamHI restriction sites of the pRS424 vector
(Christianson et al., 1992). 
 
ERV46
 
 and its flanking regions of 
 
z
 
300 bp
were amplified using primers YAL042w-NotI and YAL042w-BamHI and
inserted into the NotI and BamHI sites of the pRS426 vector (Christian-
son et al., 1992) to yield plasmid pRS426-
 
ERV46
 
. Correct amplification
and integration were verified by DNA sequencing.
For the overexpression of fusion proteins bearing NH
 
2
 
-terminal 6x his-
tidine tags, fragments of 
 
ERV41
 
,
 
 ERV46
 
, and 
 
OCH1
 
 were inserted into
the BamHI and HindIII restriction sites of the pQE-30 vector (QIAGEN)
to yield plasmids pQE-30-
 
ERV41
 
, pQE-30-
 
ERV46
 
, and pQE-30-
 
OCH1
 
,
respectively. Primers YML067c-pQE-F and YML067c-pQE-R for
 
ERV41
 
, YAL042w-pQE-F and YAL042w-pQE-R for 
 
ERV46
 
,
 
 
 
and prim-
ers OCH1-pQE-F and OCH1-pQE-R for 
 
OCH1
 
 were used to amplify
portions of these genes from genomic RSY255 DNA.
 
Strain Construction
 
ERV41
 
 was targeted for disruption with the 
 
HIS3
 
 gene (Baudin et al.,
1993). An 
 
erv41::HIS3
 
 construct was amplified using primers YML067c-
KO-F and YML067c-KO-R and pHISKO as a template. The product con-
tains the 
 
HIS3
 
 gene flanked by 43-bp upstream of the 
 
ERV41 
 
start codon
and 45-bp downstream of the 
 
ERV41
 
 stop codon and was used to trans-
form CBY453 cells. Several transformants showing histidine prototrophy
were screened by PCR using primers YML067c-NotI and HIS3. One
(CBY763) tested positive and was sporulated. Strains carrying 
 
erv46
 
D
 
,
 
rer1
 
D
 
,
 
 
 
or 
 
erv29
 
D
 
 null alleles disrupted with a 
 
KAN
 
 marker were gener-
ated by a deletion project (Winzeler et al., 1999; Research Genetics) and
crossed several times through the FY833/FY834 background to yield an
isogenic set of spores.
Erv46p, Erv41p, and Erv29p were tagged at their NH
 
2
 
 termini by the
addition of three repeated influenza virus hemagglutinin (HA) epitopes
and put under control of the 
 
GAL1
 
 promoter (Longtine et al., 1998): plas-
mid pFA6a-His3MX6-PGAL1-3HA and primers YAL042w-F4 and
YAL042w-R3 were used to amplify the construct targeted to the 
 
ERV46
 
locus. CBY453 cells were transformed with this product and selected for
histidine prototrophy. Several isolates were grown in YP with 2% galac-
tose and 0.2% glucose and screened for expression of tagged protein by
Western blot of membrane fractions using an anti-HA antibody. Approxi-
mately
 
 
 
50% of transformants tested positive, and one (CBY767) was
sporulated to yield strains CBY770 and CBY771. 
 
ERV41
 
 was targeted
with a PCR product obtained using plasmid pFA6a-TRP1-PGAL1-3HA
and primers YML067c-F4 and YML067c-R3. Transformants were se-
lected for tryptophan prototrophy and screened for expression of HA-
tagged protein. One positive diploid strain (CBY782) was sporulated
 
to obtain strains CBY783 and CBY784. Primers YGR284c-F4 and
YGR284c-R3 and plasmid pFA6a-His3MX6-PGAL1-3HA were used to
amplify the construct directed to the 
 
ERV29
 
 locus. CBY453 cells were
transformed and selected for growth on minimal media lacking histidine.
Three transformants were screened by Western blot with the anti-HA an-
tibody, and one tested positive (CBY950). Yif1p was tagged by the inser-
tion of three HA epitopes at its COOH terminus (Longtine et al., 1998),
using primers MHF2 and MHR1 and plasmid pFA6a-3HA-His3MX6 as
template. FY834 cells were transformed with the PCR product and se-
lected for histidine prototrophy. 7 out of 10 transformants expressed
tagged protein, and one was analyzed further (CBY801).
 
Genetic Analyses
 
To generate strains carrying multiple mutations, 
 
erv14
 
D
 
,
 
 erv41
 
D
 
,
 
 
 
and
 
erv46
 
D
 
,
 
 
 
strains were mated with other mutants. If possible, diploids were
selected using markers of the parent strains, otherwise, zygotes were
picked under the microscope. Diploid strains were sporulated, and asci
were dissected on YPD plates using a micromanipulator. Plates were incu-
bated at room temperature, and germinated spores were scored for mat-
ing types, markers, and growth on YPD plates at 16
 
8
 
C, room temperature,
30
 
8
 
C, 36
 
8
 
C, and 38
 
8
 
C. In cases where several loci had been replaced by the
 
HIS3
 
 gene, deletions were scored by PCR using YML067c-NotI and
the 
 
HIS3
 
 internal primer for the detection of the 
 
erv41::HIS3 
 
allele and
the 
 
ERV14
 
 specific primer GP3 (Powers and Barlowe, 1998) and the inter-
nal 
 
HIS3
 
 primer to detect the 
 
erv14::HIS3
 
 deletion. In cases where one of
the parent strains had a genetic background different from FY833/FY834,
spores were backcrossed several times to obtain isogenic strains.
 
Antibodies and Immunoblotting
 
Polyclonal antibodies were raised against 6x histidine–tagged NH
 
2
 
-termi-
nal fusion proteins of fragments of Erv41p (amino acid positions 75–274),
Erv46p (amino acid positions 80–296), and Och1p (amino acid positions
302–480) expressed from plasmids pQE-30-
 
ERV41
 
, pQE-30-
 
ERV46
 
, and
pQE-30-
 
OCH1
 
, respectively. All of the recombinant proteins localized to
the insoluble fraction of cells disrupted in a French Press. These fractions
were solubilized with 8 M urea, and the fusion proteins were purified on
Ni-NTA agarose (QIAGEN) as recommended by the manufacturer.
The recombinant proteins were used to immunize rabbits according to
standard procedures. For Western blotting, these antisera were diluted
1:1,000.
Antibodies directed against carboxypeptidase Y (CPY), Emp47p,
Erv14p, Erv25p, Kar2p, plasma membrane ATPase, Sec12p, Sec23p,
Sec61p (Powers and Barlowe, 1998), Bos1p (Cao and Barlowe, 2000),
Rer1p (Boehm et al., 1997), and Yip1p (Yang et al., 1998) were described
earlier. A monoclonal anti-HA antibody was obtained from Berkeley An-
tibody Co. Western blots were developed using the ECL method (Amer-
sham Pharmacia Biotech). For densitometric analysis, films were scanned
and plotted using NIH Image 1.52.
 
Subcellular Fractionation
 
Membrane fractions were prepared by the bead-beat method in lysis
buffer (25 mM Hepes, pH 7.0, 50 mM potassium acetate, 2 mM EDTA, 1
mM PMSF). Pellets were resolved on 12.5% polyacrylamide gels. Mi-
crosomes (Wuestehube and Schekman, 1992) and semiintact cells (Baker
et al., 1988) were prepared as described. Sucrose gradient fractionation of
membrane organelles was performed according to Powers and Barlowe
(1998). To determine whether Erv41p and Erv46p are integral membrane
proteins, semiintact FY834 cells were suspended in buffer (20 mM Hepes,
pH 7.0, 150 mM potassium acetate, 2 mM EDTA), in buffer with 1% Tri-
ton X-100, or in 0.1 M sodium carbonate, pH 11.0, 2 mM EDTA, incu-
bated on ice for 10 min and centrifuged at 60,000 rpm in a TLA100.3 rotor
(Beckman Coulter) for 12 min. Equivalent amounts of the total, superna-
tant, and pellet fractions were resolved on a 12.5% polyacrylamide gel.
 
In Vitro Vesicle Budding and Transport Assays
 
The synthesis of COPII vesicles was performed on a preparative scale by
incubating washed microsomes in the absence or presence of the proteins
Sar1p, Sec13–31p complex, and Sec23–24p complex as described previ-
ously (Barlowe et al., 1994; Belden and Barlowe, 1996). After collection of
fractions from nycodenz density gradients, peak fractions were diluted
fourfold with buffer 88 and centrifuged at 60,000 rpm for 25 min in a
TLA100.3 rotor (Beckman Coulter) to collect vesicles. The membrane pel- 
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lets were dissolved in 40 
 
m
 
l of sample buffer, and solubilized proteins were
resolved on a 15% polyacrylamide gel (Novex). Gels were developed with
a colloidal blue staining kit (Novex), and polypeptide staining bands were
excised for analysis by mass spectrometry as described (Jensen et al.,
1999). Analytical scale budding reactions were performed as described
(Barlowe et al., 1994), and packaging efficiencies were determined by den-
sitometry of scanned blots. Vesicle tethering and fusion assays following
 
35
 
S-labeled glyco-pro–
 
a
 
 factor (gp-
 
a
 
-F) were described by Cao et al.
(1998). The data plotted in these experiments are the average of duplicate
determinations, and the error bars represent the range. Pulse–chase exper-
iments were performed according to Belden and Barlowe (1996).
 
Immunoprecipitation Experiments
 
Microsomes were solubilized on ice with buffer 88 containing 2% Triton
X-100 and 1 mM PMSF for 5 min, followed by a centrifugation at 14,000 
 
g
 
for 5 min. Portions (25 
 
m
 
l) of the supernatant were mixed with 1 ml of IP
buffer (15 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100), 25 
 
m
 
l
of a 50% protein A–Sepharose slurry (Amersham Pharmacia Biotech),
and a saturating amount of anti-HA antibody and were incubated at 4
 
8
 
C
for 2 h. The precipitates were washed four times with cold IP buffer,
eluted from the beads by heating at 95
 
8
 
C in sample buffer, and resolved
on polyacrylamide gels.
 
Results
 
Identification of ERV Proteins
 
A protocol to generate ER-derived vesicles in vitro from
washed microsomes and purified COPII components
(Barlowe et al., 1994) was scaled up to prepare sufficient
amounts of material to observe polypeptides on protein-
stained polyacrylamide gels (Belden and Barlowe, 1996).
A set of polypeptides was observed (Fig. 1), and individual
bands were subjected to tryptic peptide mass mapping by
matrix-assisted laser desorption/ionization mass spectrom-
etry followed by sequence database searching as described
(Shevchenko et al., 1996; Jensen et al., 1999). Several pro-
teins were identified, some that had been previously de-
scribed and others that had not been characterized. Impor-
tantly, three of these proteins (Erv14p, Emp24p, and
Erv25p) had been identified in our initial approaches us-
ing automated NH
 
2
 
-terminal sequencing (Belden and Bar-
lowe, 1996; Powers and Barlowe, 1998). Therefore, the iso-
lated ER-derived vesicles are comparable to previous
preparations, which suggests that this method should allow
for the identification of additional Erv proteins. The
SNARE protein Bet1p (Newman and Ferro-Novick, 1987)
was also identified in this preparation and had been previ-
ously detected on ER-derived vesicles by immunoblot
analysis and is required for transport between the ER and
Golgi (Newman et al., 1992; Cao and Barlowe, 2000).
Nine other polypeptides identified in this preparation
had not been localized to ER-derived vesicles before.
Yip3p, Rer1p, Erp1p, Erp2p, Yif1p, and Emp47p are con-
served proteins that had been characterized and are
thought to operate in transport through the early secretory
pathway (Sato et al., 1995; Schröder et al., 1995; Andrulis
et al., 1998; Yang et al., 1998; Marzioch et al., 1999).
Erv29p, Erv41p, and Erv46p represent uncharacterized
proteins. Peptides derived from the Erv29p band corre-
spond to the ORF YGR284c that encodes a nonessential
35-kD integral membrane protein terminating in the se-
quence KKKIY. According to its apparent molecular
weight on polyacrylamide gels, we have designated this
protein Erv29p. YML067c encodes an uncharacterized
protein that has recently been immunoisolated from an
early Golgi compartment (Cho et al., 2000). We have des-
ignated this protein Erv41p according to its molecular
weight. YAL042w encodes a protein of unknown function
that was named Fun9p (“function unknown”) (Coleman et
al., 1986; Diehl and Pringle, 1991) but not further charac-
terized. We propose to name this protein Erv46p referring
to its localization and molecular weight.
 
Selective Packaging of Erv Proteins In Vitro
 
Authentic Erv proteins should be selectively and effi-
ciently packaged into ER-derived vesicles in the presence
of COPII proteins. To test specific packaging of the un-
characterized proteins, we first generated strains that con-
tained epitope-tagged versions of these proteins. Strain
CBY801 expresses a COOH terminally HA-tagged ver-
sion of Yif1p that fully complements for 
 
YIF1
 
 func-
tion. Erv29p (CBY950), Erv41p (CBY782), and Erv46p
(CBY767) were modified to contain the 3HA epitope at
their NH
 
2
 
 termini and were placed under the control of
Figure 1. Identification of Erv proteins. COPII-coated vesicles
were synthesized in vitro from ER membranes in the presence of
COPII proteins (1), were solubilized in sample buffer, and were
resolved on a 15% polyacrylamide gel. As a negative control, a
mock reaction without COPII proteins (2) was performed. Pro-
teins were silver stained for this figure. For mass spectroscopy,
proteins were stained with colloidal blue, and individual bands
were excised. 
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Table I. Strain List
 
Strain Genotype Reference
 
FY833
 
MAT
 
a
 
 his3200 ura3-52 leu21 lys2202 trp163
 
Winston et al. (1995)
FY834
 
MAT
 
a
 
 his3200 ura3-52 leu21 lys2202 trp163
 
Winston et al. (1995)
RSY255
 
MAT
 
a
 
 ura3-52 leu2-3,-112
 
Kaiser and Schekman (1990)
RSY263
 
MAT
 
a
 
 sec12-4 ura3-52 leu2-3,112
 
Kaiser and Schekman (1990)
RSY265
 
MAT
 
a
 
 sec13-1 ura3-52 his4-619
 
Kaiser and Schekman (1990)
RSY267
 
MAT
 
a
 
 sec16-2 ura3-52 his4-619
 
Kaiser and Schekman (1990)
RSY277
 
MAT
 
a
 
 sec21-1 ura3-52
 
Kaiser and Schekman (1990)
RSY281
 
MAT
 
a
 
 sec23-1 ura3-52 his4-619
 
Kaiser and Schekman (1990)
RSY309
 
MAT
 
a
 
 sec12-1 leu2-3,112
 
Kaiser and Schekman (1990)
RSY962
 
MAT
 
a
 
 sec35-1 lys2-801
 
Wuestehube et al. (1996)
RSY976
 
MAT
 
a
 
 ura3-52 ypt1-3
 
Wuestehube et al. (1996)
CBY99 FY834 with
 
 emp24::LEU2
 
Belden and Barlowe (1996)
CBY263
 
MAT
 
a 
 
trp1-1 ade2-1 ura3-1 leu2-3,112 can1-100 sed5-1
 
Cao et al. (1998)
CBY300 FY834 with
 
 uso1-1
 
Barlowe (1997)
CBY356 FY834 with
 
 erv14::HIS3
 
Powers and Barlowe (1998)
CBY358 FY833 with 
 
erv14::HIS3
 
Powers and Barlowe (1998)
CBY453 FY833 x FY834 Powers and Barlowe (1998)
CBY763 CBY453 diploid with 
 
ERV41/erv41::HIS3
 
This study
CBY767 CBY453 diploid with 
 
ERV46/ERV46::HIS3MX6-PGAL1-3HA
 
This study
CBY770 FY834 with 
 
ERV46::HIS3MX6-PGAL1-3HA
 
This study
CBY771 FY833 with 
 
ERV46::HIS3MX6-PGAL1-3HA
 
This study
CBY782 CBY453 diploid with 
 
ERV41/ERV41::TRP1-PGAL1-3HA
 
This study
CBY783 FY834 with 
 
ERV41::TRP1-PGAL1-3HA
 
This study
CBY784 FY833 with 
 
ERV41::TRP1-PGAL1-3HA
 
This study
CBY794 FY833 with 
 
erv41::HIS3 erv46::KAN This study
CBY795 FY834 with erv41::HIS3 erv46::KAN This study
CBY796 FY833 with erv41::HIS3 This study
CBY797 FY834 with erv41::HIS3 This study
CBY798 FY833 with erv46::KAN This study
CBY799 FY834 with erv46::KAN This study
CBY801 FY834 with YIF1::HIS3MX6-3HA This study
CBY822 FY833 with erv14::HIS3 erv46::KAN This study
CBY823 FY834  with  erv14::HIS3 erv46::KAN This study
CBY825 FY834 with erv14::HIS3 erv41::HIS3 This study
CBY826 FY833 with erv14::HIS3 erv41::HIS3 This study
CBY829 FY834 with ypt1-3 This study
CBY831 FY833 with emp24::LEU2 erv41::HIS3 erv46::KAN This study
CBY832 FY834 with emp24::LEU2 erv41::HIS3 erv46::KAN This study
CBY836 CBY822 containing pRS426-ERV46 This study
CBY840 FY833 with erv41::HIS3 ypt1-3 This study
CBY841 FY834 with erv41::HIS3 ypt1-3 This study
CBY842 FY833 with erv46::KAN ypt1-3 This study
CBY843 FY834 with erv46::KAN ypt1-3 This study
CBY844 FY833 with erv41::HIS3 erv46::KAN ypt1-3 This study
CBY845 FY834 with erv41::HIS3 erv46::KAN ypt1-3 This study
CBY847 CBY826 containing pRS424-ERV41 This study
CBY848 FY833 with erv41::HIS3 sec21-1 This study
CBY849 FY834 with erv41::HIS3 sec21-1 This study
CBY850 FY833 with erv46::KAN sec21-1 This study
CBY851 FY834 with erv46::KAN sec21-1 This study
CBY852 FY834 with erv41::HIS3 erv46::KAN sec21-1 This study
CBY853 FY833 with erv41::HIS3 sed5-1 This study
CBY854 FY833 with ade2-1 erv46::KAN sed5-1 This study
CBY855 FY834 with erv46::KAN sed5-1 This study
CBY856 FY833 with erv41::HIS3 erv46::KAN sed5-1 This study
CBY857 FY834 with ade2-1 erv41::HIS3 erv46::KAN sed5-1 This study
CBY859 FY833 with erv41::HIS3 sec12-1 This study
CBY860 FY834 with erv41::HIS3 sec12-1 This study
CBY861 FY833 with erv46::KAN sec12-1 This study
CBY862 FY834 with erv46::KAN sec12-1 This study
CBY863 FY833 with erv41::HIS3 erv46::KAN sec12-1 This study
CBY877 FY833 with erv14::HIS3 rer1::KAN This study
CBY878 FY834 with erv14::HIS3 rer1::KAN This study
CBY884 FY833 with erv41::HIS3 nce102::KAN This study
CBY885 FY834 with erv41::HIS3 nce102::KAN This studyOtte et al. Erv Proteins 507
the GAL1 promoter (Longtine et al., 1998). Galactose in-
duction resulted in stable expression of these tagged pro-
teins and localization to ER membranes. However, we
cannot assess if these proteins are fully functional because
ERV29, ERV41, and ERV46 are not essential. In vitro
budding experiments were performed with microsomes
from these strains (Fig. 2 A), and the relative packaging
efficiencies were determined by comparing the lanes that
represent 10% of the complete reactions (T) with the
lanes that contain vesicles synthesized in the presence of
COPII (1). Yif1p-3HA (8%), 3HA-Erv29p (13%), 3HA-
Erv46p (10%), and 3HA-Erv41p (13%) were incorpo-
rated into vesicles at levels comparable to the positive con-
trols Erv25p (14% for CBY801 and 5% for CBY950) and
the v-SNARE Bos1p (11 for CBY767 and 5% for
CBY782), whereas the ER resident proteins Sec12p and
Sec61p were excluded. These results indicate that Yif1p,
Erv29p, Erv41p, and Erv46p are selectively packaged into
COPII vesicles.
Next, we prepared or obtained specific polyclonal anti-
bodies against several of the newly identified Erv proteins
to measure their packaging efficiencies when endogenously
expressed. As seen in Fig. 2 B, vesicles budded from wild-
type microsomes contained Erv41p and Erv46p at levels
(20% and 26%, respectively) that are higher than those of
HA-tagged versions. Yip1p was packaged very efficiently
(65%), as was Rer1p (51%; Sato et al., 1995). The early
Golgi marker Och1p (Nakayama et al., 1992) was packaged
to a significantly lesser extent (8%). The positive controls
Erv14p, Erv25p, and Bos1p were efficiently packaged,
whereas the ER marker proteins Sec12p, Sec61p, and
Kar2p were excluded. Thus, Erv29p, Erv41p, Erv46p,
Yif1p, Yip1p, and Rer1p meet the initial requirement of
Erv proteins as they are selectively exported from ER
membranes under reconstituted vesicle budding conditions.
Molecular Characterization of Erv41p and Erv46p
For the remainder of this report, we investigate the
Erv41p and Erv46p proteins and their potential role in
transport through the early secretory pathway. Erv29p will
be described elsewhere. Erv41p is encoded by the ORF
YML067c on chromosome XIII, and conceptual transla-
Table I. continued
Strain Genotype Reference
CBY893 FY833 with erv14::HIS3 erv41::HIS3 erv46::KAN This study
CBY894 FY834 with erv14::HIS3 erv41::HIS3 erv46::KAN This study
CBY909 FY833 with erv46::KAN uso1-1 This study
CBY910 FY834 with erv46::KAN uso1-1 This study
CBY911 FY833 with erv41::HIS3 uso1-1 This study
CBY912 FY834 with erv41::HIS3 uso1-1 This study
CBY913 FY833 with erv41::HIS3 erv46::HIS3 uso1-1 This study
CBY914 FY834 with erv41::HIS3 erv46::HIS3 uso1-1 This study
CBY915 FY833 with erv46::KAN sec23-1 This study
CBY916 FY834 with erv46::KAN sec23-1 This study
CBY917 FY833 with erv41::HIS3 sec23-1 This study
CBY918 FY833 with erv41::HIS3 erv46::KAN sec23-1 This study
CBY919 FY834 with erv41::HIS3 erv46::KAN sec23-1 This study
CBY920 FY833 with erv46::KAN sec16-2 This study
CBY921 FY834 with erv46::KAN sec16-2 This study
CBY922 FY833 with erv41::HIS3 sec16-2 This study
CBY923 FY834 with erv41::HIS3 sec16-2 This study
CBY924 FY834 with erv41::HIS3 erv46::KAN sec16-2 This study
CBY930 FY834 with erv41::HIS3 erv46::KAN sec13-1 This study
CBY931 FY833 with erv41::HIS3 erv46::KAN sec13-1 This study
CBY932 FY834 with erv41::HIS3 sec13-1 This study
CBY933 FY834 with erv46::KAN sec13-1 This study
CBY934 FY833 with erv46::KAN sec13-1 This study
CBY940 FY833 with erv46::KAN sec35-1 This study
CBY941 FY834 with erv46::KAN sec35-1 This study
CBY942 FY833 with erv41::HIS3 sec35-1 This study
CBY943 FY834 with erv41::HIS3 sec35-1 This study
CBY944 FY833 with erv41::HIS3 erv46::KAN sec35-1 This study
CBY945 FY834 with erv41::HIS3 erv46::KAN sec35-1 This study
CBY948 FY833 with erv41::HIS3 rer1::KAN This study
CBY949 FY834 with erv41::HIS3 rer1::KAN This study
CBY950 CBY453 diploid with ERV29/ERV29::HIS3MX6-PGAL1-3HA This study
CBY963 FY833 with erv14::HIS3 rer1::KAN This study
CBY964 FY834 with erv14::HIS3 rer1::KAN This study
CBY965 FY833 with erv29::KAN This study
CBY966 FY834 with erv29::KAN This study
CBY967 FY833 with erv29::KAN erv41::HIS3 This study
CBY968 FY834 with erv29::KAN erv41::HIS3  This study
CBY969 FY833 with erv14::HIS3 erv29::KAN This study
CBY970 FY834 with erv14::HIS3 erv29::KAN This studyThe Journal of Cell Biology, Volume 152, 2001 508
tion yields a protein of 352–amino acid residues and a pre-
dicted molecular weight of 40.6 kD. The ORF YAL042w
on chromosome I encodes Erv46p, a protein predicted to
be composed of 415–amino acid residues with a molecular
weight of 46 kD. Database alignments showed that Erv41p
and Erv46p exhibit significant sequence similarity. Both
proteins also have one putative homologue each in Cae-
norhabditis elegans, Drosophila melanogaster,  and  hu-
mans, however, no known functions have been reported
for these proteins. Sequence identity scores (Table III) be-
tween Erv41p and its homologues (CDA14, EG:65F1.1
and C18B12.6) are higher than those between Erv41p and
Erv46p. Similarly, Erv46p and its homologues in other
species (the 43.2-kD protein, CG70, and K09E9.2) show
even higher identity scores. The Erv46p group is further
characterized by eight conserved cysteine residues in their
NH2-terminal half. Erv46p also terminates in the COPI
binding motif KKXX (Jackson et al., 1990; Cosson and Le-
tourneur, 1994), a feature that is conserved across species.
These results suggest that a conserved set of Erv41p–
Erv46p proteins are found in other species and are likely
to perform a similar function.
ERV41 as well as ERV46 were amplified from genomic
DNA and inserted into the multicopy shuttle vectors
pRS424 and pRS426, respectively, to yield plasmids
pRS424-ERV41 and pRS426-ERV46. Polyclonal antisera
were raised against recombinant forms of Erv41p and
Erv46p and then tested on wild-type, deletion, and over-
Table II. Primer Sequences
Primer Sequence
YML067c-NotI 59-ATAAGAATGCGGCCGCAACTCCCCTTCTCCAGACTTG-39
YML067c-BamHI 59-CGCGGATCCGCGAAGTATGCGGGACGCTG-39
YAL042w-NotI 59-ATAAGAATGCGGCCGCCTGCAGATGACATTGCGCTGC-39
YAL042w-BamHI 59-CGCGGATCCGCCATGATCTCTCGGGTTGG-39
YML067c-pQE-F 59-CGCGGATCCACGAAATGTGATTGGTTGC-39
YML067c-pQE-R 59-CCCAAGCTTCACCTTTAGCAGCGACATC-39
YAL042w-pQE-F 59-CGCGGATCCTGTGACCTGGTGAATCTCG-39
YAL042w-pQE-R 59-CCCAAGCTTCCTGTCCGGGAACACC-39
OCH1-pQE-F 59-CGCGGATCCGATCCAAGATTTGAAGAAG-39
OCH1-pQE-R 59-CCCAAGCTTGGGTATGATGAAAGGAGAG-39
YML067c-KO-F 59-TGCTTTTGCTGTAACGTACAGGCAGAGACTTCAGGAGTATATAGGCCTCCTCTAGTACACTC-39
YML067c-KO-R 59-GAAACGTTATCTTGGGTATACTGCATTCTCTTTTCTTTTACATATGCGCGCCTCGTTCAGAATG-39
HIS3 59-GCCTCATCCAAAGGCGC-39
YAL042w-F4 59-CGCCATTATAAAGGAAAGCTAGTTTTATGTCTCGTATACAGAATTCGAGCTCGTTTAAAC-39
YAL042w-R3 59-TAGCGAATGCGTCCAGCGACAGCAACGTGGACCTTTTCATGCACTGAGCAGCGTAATCTG-39
YML067c-F4 59-GATATTATCAATGTTCTATTCTTACTGAGAAAAGCGTTCCGAATTCGAGCTCGTTTAAAC-39
YML067c-R3 59-ATAACATACGAAACGCATCAAATGTCTTCAATCCTGCCATGCACTGAGCAGCGTAATCTG-39
YGR284c-F4 59-ACGAAAGATCAAAGGTGTCCTTATTTACTTACAATAGCTGGAATTCGAGCTCGTTTAAAC-39
YGR284c-R3 59-GGCATACCGCCAAAATTTCCAATAGGTCCTCTGTAAGACATGCACTGAGCAGCGTAATCTG-39
MHF2 59-TGGCTTCATTTGGCAAAATGTTCTAATGTGGTTAATGGGTCGGATCCCCGGGTTAATTAA-39
MHR1 59-GCATGAAATTAAATCCTCTCTTTGATCTCTTCAATCAAGAGAATTCGAGCTCGTTTAAAC-39
Figure 2. Selective packaging of Erv proteins into COPII-coated
vesicles in vitro. (A) In vitro budding reactions with microsomes
prepared from strains expressing tagged versions of Erv proteins:
Yif1p-3HA (CBY801), 3HA-Erv29p (CBY950), 3HA-Erv46p
(CBY767), and 3HA-Erv41p (CBY782). One tenth of a total re-
action (T), budded vesicles isolated after incubation with COPII
proteins (1), or a mock reaction without COPII proteins (–)
were separated on a 12.5% polyacrylamide gel. Tagged proteins
were visualized by immunoblot with an anti-HA antibody, and
Sec61p or Sec12p (ER resident proteins) as negative controls and
Erv25p (Erv protein) or Bos1p (v-SNARE) as positive controls
were detected using polyclonal antisera. (B) In vitro budding re-
actions with FY834 wild-type microsomes. The same budding
protocol as in A was used. Proteins were detected with polyclonal
antisera against Sec12p, Kar2p, and Sec61p (ER residents),
Bos1p (v-SNARE), Och1p (early Golgi marker), and the Erv
proteins Erv46p, Erv41p, Erv25p, Erv14p, Rer1p, and Yip1p.Otte et al. Erv Proteins 509
producing strains to confirm their specificity (Fig. 3). No
immunoreactive species were detected in the deletion
strains, whereas the heterozygous diploid strains carrying
one wild-type and one tagged copy of the respective genes
expressed two immunoreactive species at the expected
size. This result also demonstrated that expression levels
from the GAL1 promoter were comparable to wild-type
expression levels at a concentration of 1.5% galactose.
Strains harboring ERV41 or ERV46 on 2m based multi-
copy plasmids expressed slightly higher levels of Erv41p or
Erv46p than wild-type strains.
Both Erv41p and Erv46p contain two segments of suffi-
cient length and hydrophobicity to form transmembrane do-
mains, and the short NH2- and COOH-terminal regions of
both proteins are predicted to be located on the cytoplasmic
side with a large lumenal domain separating the two trans-
membrane regions. The hydrophilicity plots of both proteins
are superimposable (Fig. 4 A), and a similar topology is pre-
dicted for all of the known homologues. There is no evi-
dence for a cleavable signal sequence. To confirm that
Erv41p and Erv46p are indeed integral membrane proteins,
we examined their fractionation behavior under conditions
that release lumenal and peripherally bound membrane pro-
teins (carbonate buffer, pH 11.0) or solubilize integral mem-
brane proteins (1% Triton X-100). The fractionation profile
for Erv41p and Erv46p was the same as for the integral
membrane protein Bos1p, as they could only be solubilized
by detergent and not by carbonate treatment (Fig. 4 B).
The abundant Erv proteins are hypothesized to cycle
between the ER and Golgi (Belden and Barlowe, 1996;
Powers and Barlowe, 1998) because they localize to both
of these membrane compartments, and, in contrast to
abundant secretory proteins, their levels are not dimin-
ished by cycloheximide treatment (Yeung et al., 1995).
Therefore, we examined the subcellular localization of
Erv41p and Erv46p by resolution of membrane or-
ganelles on sucrose gradients (Fig. 5). Erv41p and
Erv46p sedimented in two peaks, one that coincided
with the Golgi marker Emp47p and the other with the
ER marker Kar2p. This subcellular localization pattern
was similar to that of Erv14p (Powers and Barlowe,
1998) and Erv25p (Belden and Barlowe, 1996). Rer1p
has been shown to be predominantly localized to the
Golgi (Sato et al., 1995) and to recycle between the
Golgi and ER (Boehm et al., 1997). Consequently, we
find that the majority of Rer1p cosedimented with
Emp47p, and a second smaller peak cosedimented with
Kar2p. In contrast, Och1p was localized almost exclu-
sively to the Golgi. The localization of the epitope-
tagged Erv46p was also examined by indirect immuno-
fluorescence using the anti-HA antibody (data not
shown). We observed a perinuclear staining pattern that
partially overlapped with the ER marker Kar2p and was
similar to that described for Erv14p (Powers and Bar-
lowe, 1998). We conclude that Erv41p and Erv46p local-
ize to the early secretory pathway.
Table III. Percent Sequence Identities between Erv46p, Erv41p, and Their Homologues
Erv46p Erv41p K09E9.2 C18B12.6 CG7011 EG:65F1.1 43.2 kD CDA14
Erv46p (S. cerevisiae) 100 28 38 12 38 27 41 25
Erv41p (S. cerevisiae) 100 32 25 28 32 31 30
K09E9.2 (C. elegans) 100 20 41 27 43 32
C18B12.6 (C. elegans) 100 20 20 17 21
CG7011 (D. melanogaster) 100 27 47 34
EG:65F1.1 (D. melanogaster) 100 31 35
43.2 kD protein (H. sapiens) 100 38
CDA14 (H. sapiens) 100
Full-length sequences were aligned using the CLUSTAL V algorithm of GeneInspector v1.5 with the BLOSUM62 table and default settings (k-tuple 1, maximum gap length 5,
gap penalty 3, 5 top diagonals).
Figure 3. Immunoblot analy-
sis of wild-type, erv41D, and
erv46D deletion and over-
producing strains. FY834
wild-type (wt), erv46D (46D,
CBY799), and erv41D (41D,
CBY797) strains were grown
in YPD medium. Heterozy-
gous diploid strains express-
ing NH2 terminally 3HA-
tagged Erv46p (46/HA46,
CBY767) or Erv41p (41/
HA41, CBY782) were grown
in YP with 1.5% galactose
and 0.5% glucose. erv14D
erv46D deletion strains car-
rying pRS426-ERV46 plasmid (2m 46, CBY836) or pRS424-ERV41 plasmid (2m 41, CBY847) were grown in minimal media lacking
uracil or tryptophan, respectively. Membrane fractions were resolved on a 12.5% polyacrylamide gel and immunoblotted with an anti-
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Analysis of the erv41D and erv46D Strains
To investigate the function of Erv41p and Erv46p, we ana-
lyzed strains bearing null alleles at the ERV41 or ERV46
loci. A PCR-based approach was used to direct the HIS3
gene to the ERV41 locus, replacing the entire ERV41 ORF.
A heterozygous ERV41/erv41D  diploid strain (CBY763)
was sporulated, and dissection of asci produced four viable
spores. Tetrad analysis of these spores for the HIS3 marker
confirmed that ERV41 was not essential for vegetative
growth, although spores carrying the deletion were slightly
delayed in their germination (data not shown). A haploid
strain in which the ERV46 reading frame had been replaced
by a KAN marker (Winzeler et al., 1999) was crossed three
times through the FY833/FY834 background to obtain the
isogenic haploid erv46D strains CBY798 and CBY799.
The haploid erv41D strains (CBY796 and CBY797)
grew at rates comparable to wild-type strains at 308C and
378C but displayed a reduced growth rate at 168C (Fig. 6
B). The cellular morphology as determined by light mi-
Figure 4. Erv46p and Erv41p are integral membrane proteins.
(A) Hydrophilicity plots according to Kyte and Doolittle (1982)
with a window size of 7. The schematic representations of the
polypeptide chains indicate the positions of the putative trans-
membrane domains (TM1 and TM2) predicted by the HMMTOP
program (Tusnady and Simon, 1998), the region containing con-
served cysteine residues (Cys) and the KKXX motif (black dot).
(B) Semiintact FY834 cells were treated with buffer (Materials
and Methods), buffer containing 1% Triton X-100 (TX100), or
0.1 M Na2CO3 (pH 11) and centrifuged at 100,000 g. Totals be-
fore centrifugation (T), supernatant (S), and pellet (P) fractions
were analyzed on a 12.5% polyacrylamide gel and immunoblot-
ted for Sec23p (peripheral membrane protein), Erv46p, Erv41p,
and Bos1p (integral membrane protein).
Figure 5. Sucrose gradient fractionation of Erv41p, Erv46p, Och1p,
and Rer1p. An FY834 whole cell lysate was separated on an 18–
60% sucrose density gradient, and fractions were collected, starting
with fraction 1 at the top. (A) Relative levels of Emp47p (Golgi
marker), Kar2p (ER marker), and plasma membrane marker
(PMA) in each fraction were quantified by densitometry of immu-
noblots. (B) Relative levels of Och1p, Erv46p, Erv41p, and Rer1p as
determined by densitometry of the immunoblots shown in C.Otte et al. Erv Proteins 511
croscopy as well as the mating and sporulation efficiencies
of an erv41D strain were indistinguishable from the
isogenic wild-type strains. Intracellular transport of the
secretory proteins CPY and Gas1p was not detectably al-
tered in an erv41D strain and the major secretory proteins
contained in culture supernatants were also unchanged
(data not shown). Therefore, deletion of ERV41 does not
appear to interfere with general secretion. We performed
a similar set of analyses on erv46D strains and observed
phenotypes that were identical to erv41D strains, notably a
reduced growth rate at 168C. Furthermore, erv41D erv46D
strains did not exhibit any exacerbated phenotypes com-
pared with the single deletions strains (Fig. 6 B).
Next, we investigated possible influences of the erv41D
and  erv46D  deletions on other mutations that impede
transport through the early secretory pathway (Table IV
and Fig. 6). First, we examined phenotypes combined with
null alleles of other known ERV genes. An erv14D strain
(CBY356) also exhibits a delayed rate of spore germina-
tion, a slightly slower growth rate in YPD at 308C (in-
crease in doubling time of z18% over the wild type), and
cold sensitivity. These phenotypes are significantly exacer-
bated by either erv41D or erv46D.  In  erv14D erv41D
(CBY825) and erv14D erv46D (CBY823) strains, germina-
tion is delayed by several days (Fig. 6 A), the doubling
time is increased by z40% compared with the wild type,
and cold sensitivity is increased. The triple erv14D erv41D
erv46D (CBY894) mutant does not show any further exac-
erbation of these phenotypes except that its germination is
extremely delayed by z1 wk at room temperature. In con-
trast to the erv14D effects, combining emp24D with erv41D
or erv46D did not alter growth phenotypes.
Also, we investigated the influences of erv41D  and
erv46D deletions on thermosensitive mutations in known
budding, tethering, and fusion genes. An erv41D  ypt1-3
strain (CBY841) showed a significantly decreased ther-
mosensitivity compared with ypt1-3 alone (CBY829). The
same effect was observed in a ypt1-3 erv41D erv46D strain
(CBY845), whereas erv46D alone slightly exacerbated the
thermosensitivity of ypt1-3 (CBY843, Fig. 6 C). In con-
trast, no effect was observed with the other tethering mu-
tations uso1-1 and sec35-1. The erv41D or erv46D null mu-
tations did not influence any of the growth phenotypes
associated with mutations in the COPI (sec21-1), COPII
(sec12-4, sec13-1, sec16-1, and sec23-1), or fusion (sed5-1)
proteins. Finally, we did not observe any synthetic effects
when the erv41D or erv46D mutations were combined with
rer1D or erv29D.
Effects of erv41D and erv46D on Transport to the Golgi
Since erv41D and erv46D strains did not exhibit major de-
fects in secretion, but the erv14D erv46D strains showed an
exacerbated growth phenotype, we examined the transport
kinetics in this strain compared with wild-type and the sin-
gle erv14D and erv46D strains. A pulse–chase experiment
was performed in which cells were grown in minimal media
and pulsed for 7 min with [35S]methionine and [35S]cysteine
to label newly synthesized proteins. Excess unlabeled cys-
teine and methionine were added for the chase phase, and
the maturation of CPY was followed by immunoprecipita-
tion with an anti-CPY antibody. CPY first appears in the
ER as the P1 precursor form of 67 kD and is then modified
in the Golgi to yield its P2 form of 69 kD and finally pro-
cessed in the vacuole to the mature M form of 61 kD
(Stevens et al., 1984). As seen in Fig. 7, a slight delay in
transport of CPY was observed in an erv14D strain (Pow-
ers and Barlowe, 1998), and, when combined with erv46D,
no further decrease in the transport rate was detected.
Figure 6. Genetic experiments with erv41D and erv46D strains. (A)
An  erv14D strain (CBY358) was mated with an erv46D strain
(CBY799), and spores were dissected on a YPD plate. Spores that
germinated and grew slower were shown to carry both deletions. (B)
Cold sensitivity of erv14D, erv41D, and erv46D strains. Wild-type
(FY834), erv46D (CBY799), erv41D (CBY797), erv14D (CBY356),
erv14D erv46D (CBY823), erv14D erv41D (CBY825), erv41D
erv46D (CBY795), and erv14D erv41D erv46D (CBY894) strains
were grown to saturation in YPD, adjusted to an OD600 of 3.0, and 5
ml of a 10-fold dilution series were spotted onto YPD plates. (C) Ef-
fects of erv41D and erv46D mutations on the ypt1-3 mutation. Wild-
type (FY834), ypt1-3 (CBY829), erv46D ypt1-3 (CBY843), erv41D
ypt1-3 (CBY841), erv41D erv46D ypt1-3 (CBY845), and erv41D
erv46D (CBY795) cells were spotted on YPD plates as in B.The Journal of Cell Biology, Volume 152, 2001 512
To further investigate a possible defect in ER to Golgi
transport, we used an in vitro transport assay that permit-
ted us to differentiate between the budding, tethering, and
fusion stages (Barlowe, 1997; Cao et al., 1998). We have
found this assay to be a more sensitive method to measure
transport between the ER and Golgi. In some instances,
mutant strains that display normal transport kinetics in
pulse–chase experiments show defects in distinct stages of
Figure 7. Pulse–chase analysis of CPY maturation in wild-type and erv14D erv46D deletion strains. Wild-type (wt, FY833), erv46D
(46D, CBY798), erv14D (14D, CBY358), and erv14D erv46D (14D 46D, CBY822) strains were pulsed for 7 min with 35S-labeled cysteine
and methionine and then chased for 10 or 20 min. Labeled CPY was immunoprecipitated from cell extracts, resolved on a 10% poly-
acrylamide gel, and visualized by autoradiography.
Table IV. Effects of erv41 and erv46
Strain number Genotype Phenotype*
FY834 wild type —
CBY356 erv14D Delayed germination, slightly slower growth, cold sensitive
CBY799 erv46D Cold sensitive
CBY797 erv41D Delayed germination, cold sensitive
CBY795 erv41D erv46D No effect 
CBY823 erv14D erv46D Slow germination, slow growth, cold sensitive 
CBY825 erv14D erv41D Very slow germination, slow growth, cold sensitive 
CBY894 erv14D erv41D erv46D Extremely slow germination, slow growth, cold sensitive 
CBY832 erv41D erv46D emp24D No effect
CBY841 erv41D ypt1-3 Significant decrease in temperature sensitivity
CBY843 erv46D ypt1-3 Slight increase in temperature sensitivity
CBY845 erv41D erv46D ypt1-3 Significant decrease in temperature sensitivity
CBY912 erv41D uso1-1 No effect
CBY910 erv46D uso1-1 No effect
CBY914 erv41D erv46D uso1-1 No effect
CBY943 erv41D sec35-1 No effect
CBY941 erv46D sec35-1 No effect
CBY945 erv41D erv46D sec35-1 No effect
CBY849 erv41D sec21-1 No effect
CBY851 erv46D sec21-1 No effect
CBY852 erv41D erv46D sec21-1 No effect
CBY853 erv41D sed5-1 No effect
CBY855 erv46D sed5-1 No effect
CBY857 erv41D erv46D sed5-1 No effect
CBY860 erv41D sec12-1 No effect
CBY862 erv46D sec12-1 No effect
CBY863 erv41D erv46D sec12-1 No effect
CBY923 erv41D sec16-2 No effect
CBY921 erv46D sec16-2 No effect
CBY924 erv41D erv46D sec16-2 No effect
CBY932 erv41D sec13-1 No effect
CBY933 erv46D sec13-1 No effect
CBY930 erv41D erv46D sec13-1 No effect
CBY917 erv41D sec23-1 No effect
CBY916 erv46D sec23-1 No effect
CBY919 erv41D erv46 sec23-1 No effect
CBY964 erv14D rer1D No effect
CBY949 erv41D rer1D No effect
CBY970 erv29D erv14D No effect
CBY968 erv29D erv41D No effect
*Conditions tested: YPD at 168C, 258C, 308C, 368C, and 388C.Otte et al. Erv Proteins 513
cell-free transport (Conchon et al., 1999). Washed semiin-
tact cells containing 35S-labeled gp-a-F bud 35S-labeled gp-
a-F–containing vesicles in the presence of COPII proteins.
Packaged 35S-labeled gp-a-F in vesicles can be quantified
by precipitation with concanavalin A–Sepharose, allowing
us to assay budding efficiencies. The vesicle tethering
stage may be monitored as the decrease in diffusible
COPII vesicles upon addition of the tethering protein
Uso1p. Lastly, reconstituted transport to the Golgi com-
plex can be measured after addition of COPII, Uso1p, and
LMA1 to semiintact cells by precipitation of Golgi-modi-
fied forms of 35S-labeled gp-a-F with a1,6-mannose–spe-
cific antiserum. As seen in Fig. 8 A, the budding and teth-
ering stages of transport were not impaired in mutant
strains compared with a wild-type strain. However, there
was a modest but significant decrease in transport to the
Golgi complex in the erv41D, erv46D, and the double
erv41D erv46D membranes (Fig. 8 B). Notably, the effects
of the single deletions were neither additive nor coopera-
tive when combined in the double mutant strain. To-
gether, these results suggest that the transport defect oc-
curred during the fusion stage of this assay. Also, we
examined transport efficiencies in the presence of a crude
cytosol to determine if the erv41D erv46D membranes re-
quired additional factors not provided by purified recon-
stitution proteins. As shown in Fig. 8 C, a similar transport
defect was observed for reactions using crude cytosol or
purified proteins to drive transport.
Association of Erv41p and Erv46p
Based on the colocalization of Erv41p and Erv46p, the
similarity in phenotypes displayed by erv41D and erv46D
in our genetic experiments and the nonadditive effects of
the erv41D and erv46D mutations on ER–Golgi transport
assays, we suspected that these proteins act together and
possibly form a complex. Therefore, we investigated
whether the expression of Erv41p and Erv46p is interde-
pendent by immunoblotting cells containing the erv41D,
erv46D, and erv41D erv46D  alleles with antisera against
Erv41p and Erv46p. The erv46D strain did not express a
detectable level of Erv41p, and the erv41D strain exhibited
a reduced expression of Erv46p compared with the wild
type (Fig. 9). Consistent with these findings, we observed
that Erv46p could be expressed at higher levels from a 2m
plasmid than Erv41p (Fig. 3). A strain carrying both
ERV41 and ERV46 on 2m plasmids did not express either
of them at levels higher than a strain just overexpressing
Erv46p (not shown). Also, the expression level of endoge-
nous Erv41p could be elevated (approximately twofold) if
Erv46p was overproduced under control of the GAL1 pro-
moter (compare the total [T] lanes in Fig. 10). These re-
Uso1p (1COPII/Uso1p) are indicated. (B) Overall transport of
35S-labeled gp-a-F to the Golgi complex in the same strains. Semi-
intact cells were incubated alone (NA) or with the reconstitution
proteins COPII, Uso1p, and LMA1 (1Recon). (C) Overall trans-
port of 35S-labeled gp-a-F factor to the Golgi complex in wild-
type (wt, FY834) and erv41D erv46D (41D 46D, CBY795) strains.
Semiintact cells were incubated alone (NA), with cytosol, or with
the reconstitution proteins COPII, Uso1p, and LMA1 (1Recon).
Figure 8. Influences of erv41D  and erv46D mutations on ER–
Golgi transport. (A) Vesicle budding and tethering in washed
semiintact cells prepared from wild-type (wt, FY834), erv41D
(41D, CBY797), erv46D (46D, CBY799), and erv41D erv46D (41D
46D, CBY795) strains. The levels of diffusible vesicles in reactions
without reconstitution proteins (NA), with COPII proteins
(1COPII), and with COPII proteins plus the tethering factorThe Journal of Cell Biology, Volume 152, 2001 514
sults indicate that the expression of Erv41p is highly de-
pendent on the presence of Erv46p, and to a lesser extent
Erv46p expression depends on the presence of Erv41p.
One interpretation of these results is that Erv41p and
Erv46p are associated in a multisubunit protein complex,
and when one of the members of this complex is absent,
the other subunit(s) is destabilized.
To determine if Erv41p and Erv46p are physically associ-
ated, we performed a native immunoprecipitation experi-
ment from detergent-solubilized membranes. Microsomes
from a wild-type strain and from a strain expressing 3HA-
Erv46p were solubilized with Triton X-100, and tagged
Erv46p was precipitated by the addition of anti-HA anti-
bodies. As seen in Fig. 10, Erv41p coprecipitated with 3HA-
Erv46p in the tagged strain, whereas no Erv41p was precipi-
tated from the untagged wild-type microsomes. As controls,
neither Sec23p nor Erv25p were precipitated, indicating
that the association of 3HA-Erv46p with Erv41p was spe-
cific. In other experiments, we found that HA-tagged
Erv41p could be coimmunoprecipitated with Erv46p when
Erv46p specific polyclonal antibodies were used (not
shown). Finally, we observed that endogenous Erv46p was
not detected in complexes that were isolated with 3HA-
Erv46p (Fig. 10; Otte, S., unpublished observation). Collec-
tively, the expression studies and immunoprecipitation
results indicate that Erv41p and Erv46p are physically asso-
ciated in a heteromeric complex and that these complexes
probably contain single Erv46p and Erv41p subunits.
Discussion
Using a reconstituted budding assay combined with mass
spectrometry, we have identified four known trans-
membrane protein constituents of COPII-coated vesicles
(Erv14p, Emp24p, Erv25p, and Bet1p), and have localized
six other characterized proteins (Yip3p, Rer1p, Erp1p,
Erp2p, Yif1p, and Emp47p) and three additional novel
proteins (Erv29p, Erv41p, and Erv46p) to these carrier
vesicles. We went on to characterize Erv41p and Erv46p,
two related proteins that are conserved across species.
Both are integral transmembrane proteins and are pre-
dicted to have large lumenal domains with shorter
COOH- and NH2-terminal cytoplasmic segments. Local-
ization studies show that both proteins reside in the Golgi
and ER at steady state. erv41D and erv46D strains are
cold-sensitive, and these deletions exacerbate the erv14D
phenotype. The erv41D and erv46D mutations also influ-
ence the thermosensitivity of a ypt1-3 strain. Strains carry-
ing the erv41D and erv46D null alleles show normal vesicle
budding and tethering but a reduced overall transport effi-
ciency between the ER and Golgi, suggesting a defect
downstream of the tethering stage. Expression of Erv41p
and Erv46p is interdependent, and both proteins could be
coimmunoprecipitated, indicating that these proteins are
physically associated.
In discussing potential functions for Erv41p and Erv46p,
it may be informative to consider other characterized vesi-
cle proteins. We have now identified four p24 proteins on
isolated ER-derived vesicles. Yeast has eight members of
this family, Erv25p (Belden and Barlowe, 1996), Emp24p
(Schimmöller et al., 1995), and Erp1p to Erp6p (Marzioch
et al., 1999). These abundant, conserved, integral type I
transmembrane proteins have been found in COPI and
COPII vesicles and have been shown to shuttle between
the ER and Golgi. Their cytosolic tails have a high affinity
for coat proteins and have been proposed to act as a scaf-
fold during the formation of the protein coat (Bremser et
al., 1999), as transport receptors for secretory cargo
(Schimmöller et al., 1995) or as negative regulators of vesi-
cle budding that influence cargo sorting (Elrod-Erickson
and Kaiser, 1996). However, a strain that lacks all eight
p24 proteins is viable and did not show defects in over-
all COPI- or COPII-mediated transport (Kaiser, 2000;
Springer et al., 2000), indicating that they do not perform
an essential role in transport through the early secretory
pathway in yeast. The phenotypes associated with p24 de-
letion strains are consistent with a role in protein and/or
lipid sorting during vesicle budding either by association
with cargo or through formation of specialized sorting re-
gions or membrane compartments. The expression levels
of the Erv25p, Emp24p, Erp1p, and Erp2p are interdepen-
dent, these proteins are found associated in a heterooligo-
meric complex, and strains lacking any one subunit of this
complex exhibit similar phenotypes (Marzioch et al.,
1999). Our detection of the Erp1p and Erp2p proteins on
COPII vesicles is consistent with these observations, and
we are testing the possibility that this heterooligomeric
p24 complex is packaged en bloc during vesicle formation.
Yip3p and Yif1p, two previously identified proteins,
were also encountered on ER-derived vesicles. The Yip
proteins were initially discovered as Ypt1p interacting
proteins (Yang et al., 1998) and Yif1p as a Yip1p interact-
Figure 9. Erv41p and Erv46p
depend on each other for
their expression. wt, wild-type
strain FY834; 46D, erv46D de-
letion strain CBY799; 41D,
erv41D  deletion strain
CBY797; and 41D 46D,
erv41D erv46D double dele-
tion strain CBY795. Semiin-
tact cells were resolved on a
12.5% polyacrylamide gel
and immunoblotted with
polyclonal anti-Erv41p and
anti-Erv46p antisera. Kar2p is
shown as a loading control.Otte et al. Erv Proteins 515
ing factor (Andrulis et al., 1998). Ypt1p is a small GTPase
required for vesicle transport through the early secretory
pathway (Rexach and Schekman, 1991; Segev et al., 1988)
and therefore the Yip and Yif proteins are thought to op-
erate in conjunction with GTPases to catalyze vesicle fu-
sion. Yip1p and Yif1p are integral membrane proteins that
localize predominantly to Golgi membranes and possess
hydrophilic NH2-terminal domains facing the cytosol. Re-
cently, a Yip1p–Yif1p complex has been proposed to func-
tion as a receptor in recruiting GTPases to specific mem-
branes, perhaps acting as a GDI displacement factor
(Yang et al., 1998; Matern et al., 2000). We find the
Yip1p–Yif1p complex is efficiently packaged into COPII
vesicles, suggesting that these proteins actively cycle be-
tween the ER and Golgi compartments. It seems possible
that the Yip1–Yif1p complex on vesicles could act directly
to target vesicles to Ypt1p on the surface of Golgi mem-
branes or Yip1p–Yif1p could perform a more general role
in recruiting GTPases to several distinct intracellular
membranes. Further studies will be needed to distinguish
between these possibilities.
Rer1p is required for the ER localization of type II
transmembrane proteins (e.g. Sec12p) and has been pro-
posed to couple retrieved proteins to the COPI coat during
retrograde Golgi to ER transport (Sato et al., 1995; Boehm
et al., 1997; Sato et al., 1997). We have found that Rer1p is
included in COPII vesicles with a high efficiency, suggest-
ing this protein actively cycles between the ER and Golgi
compartments. Our observation seems consistent with the
proposed function of Rer1p in retrieval of ER residents
from post-ER compartments. However, it remains to be
determined if the COPII-dependent forward transport of
Rer1p reflects recycling necessary to perform its function
in retrieval of ER residents or whether this protein per-
forms additional roles in anterograde transport.
We had expected that the abundant Erv proteins would
represent transport machinery involved in vesicle forma-
tion, cargo selection, and membrane fusion (Belden and
Barlowe, 1996). To a large extent, our current study bears
this out. However, we also found that the outer-chain
mannosyltransferase (Och1p) was packaged into COPII
vesicles as has been previously reported (Bednarek et al.,
1995). Och1p was not detected in our mass spectral analy-
sis, but antibodies against this protein were generated to
allow for a comparison of packaging efficiencies with
other Erv proteins. We find that Och1p is packaged into
COPII vesicles, albeit at a lower efficiency than most other
Erv proteins (Fig. 2), and is localized predominantly to
Golgi membranes (Fig. 5). The packaged Och1p could
represent newly synthesized protein in transit to the Golgi
or may belong to a class of Golgi localized proteins that
cycle between the ER and Golgi compartments at a signif-
icant rate as has been observed for mammalian galactosyl-
transferase (Zaal et al., 1999). It is interesting to note that
other Golgi localized proteins such as Ypt1p and GDPase
were not efficiently packaged into COPII vesicles (Cao
and Barlowe, 2000). Furthermore, in vivo studies indicate
that some Golgi-localized proteins cycle rapidly through
the ER, whereas others do not (Wooding and Pelham,
1998; Barrowman et al., 2000). It remains to be deter-
mined if cycling rates necessarily reflect an important
functional property. Regardless, the fact that some pro-
teins typically thought to be Golgi residents are found in
COPII vesicles suggests that uncharacterized Erv proteins
could potentially belong to this group.
Erv41p and Erv46p are predicted to have large lumenal
domains and short NH2- and COOH-terminal cytosolic
tails that potentially interact with the COPII and/or COPI
coats. Based on these and other considerations discussed
above, we can envisage a few possible roles for the
Erv41p–Erv46p complex that are consistent with our ex-
perimental observations. First, this complex could perform
Figure 10. Erv41p is coimmuno-
precipitated with HA-tagged
Erv46p. Microsomes were pre-
pared from FY833 (2 HA-
Erv46p) and CBY767 (1 HA-
Erv46p) cells grown in YP with
2% galactose and 0.2% glucose
and solubilized with buffer con-
taining 2% Triton X-100 (T).
The soluble extracts (S) were in-
cubated in absence (2 anti-HA
ab) or presence (1 anti-HA ab)
of the monoclonal anti-HA anti-
body. Precipitates were resolved
on a 12.5% polyacrylamide gel
and immunoblotted for Sec23p,
Erv46p, Erv41p, and Erv25p.The Journal of Cell Biology, Volume 152, 2001 516
a role similar to the p24 complex in sorting during vesicle
formation. The complex could fulfill this role through di-
rect interaction with cargo molecules or by establishing
domains on the surface of budding membranes. In some
respects, the heteromeric arrangement, the membrane to-
pology, and the nonessential phenotypes exhibited by the
Erv41p–Erv46p complex are reminiscent of the p24 dele-
tion strains. We have not detected any specific secretory
cargo that accumulates in the erv41D and/or erv46D dele-
tion strains, however, we currently have a very limited ca-
pability of monitoring individual secretory cargo. If the
Erv41p–Erv46p complex is required for the efficient trans-
port of a small subset of nonessential cargo proteins, we
may not easily detect an accumulation. Second, the
Erv41p–Erv46p complex could operate in the retention
and/or retrieval of transport machinery to the early secre-
tory pathway. For example, as Rer1p acts in the retrieval
of Sec12p and other ER residents, the Erv41p–Erv46p
complex could operate in localizing proteins to Golgi
membranes. In keeping with this idea, the erv41D erv46D
strain displayed a modest defect in the fusion stage of in
vitro transport between the ER and Golgi, suggesting the
Erv41p–Erv46p complex could interact with or serve to
correctly localize the membrane fusion machinery (e.g.,
SNAREs and SNARE regulatory proteins). Third, the
Erv41p–Erv46p complex may not act in movement or lo-
calization of proteins, but could be involved in lipid trans-
port. A majority of cellular phospholipid, glycolipid, and
sterol synthesis occurs in the ER (for review see Daum et
al., 1998), and it seems probable that specific proteins act
to sort and transport these species to their proper location.
Although nonsecretory routes exist for lipid transport,
much of this lipid transport occurs through the classical
secretory pathway and presumably through COPII vesi-
cles. Therefore, the observed in vitro defect during the
vesicle fusion stage could be caused by a suboptimal lipid
composition of vesicle or acceptor membrane bilayers,
leading to a reduction in membrane fusion efficiency. Fi-
nally, the Erv41p–Erv46p complex could perform a role in
the posttranslational maturation of secretory proteins such
as protein folding or glycosylation in the early secretory
pathway. If this last possibility were the case, we again
would speculate that the effect is on a subset of secretory
cargo because we do not detect any general defects in fold-
ing, no extracellular secretion of kar2p (Otte, S., unpub-
lished observation), and no obvious alterations in N- or
O-linked oligosaccharide modifications.
Several recent reports suggest a role for COPII-depen-
dent transport in regulation of cellular homeostasis (Niwa
et al., 1999; Nohturfft et al., 2000; Travers et al., 2000). Al-
though the underlying mechanisms of these regulatory
pathways remain to be elucidated, our investigation of Erv
proteins may shed light on these questions. Notably, sev-
eral of the proteins we have identified on COPII vesicles,
including the novel proteins Erv29p, Erv41p, and Erv46p,
are induced upon activation of the unfolded protein re-
sponse pathway (Travers et al., 2000). With respect to the
Erv41p–Erv46p complex, it will be important to determine
binding partners that potentially include additional mem-
bers of the heteromeric Erv41p–Erv46p complex, vesicle
coat proteins, and/or specific cargo molecules. We will
combine these biochemical approaches with cell-free
transport assays and molecular genetic analyses of Erv41p–
Erv46p to elucidate their function.
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